Antibody-mediated inhibition of OLFML3, as well as genetic silencing of Olfml3, resulted in reduced tumor vascularization and growth, which ultimately prolonged survival in mouse models of lung and colorectal cancer [19,20]. The gene discussed is OLFML3; the disease is colorectal cancer.